Kumi Yasukawa

A genome-wide association study identifies three new risk loci for Kawasaki disease

Yoshihiro Onouchi, Kouichi Ozaki, Jane C. Burns et al. · Nature Genetics · 2012 · 337 citations

Life Sciences, Genetics, Molecular Genetics +13

Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a randomised controlled, open-label, blinded-endpoints, phase 3 trial

Hiroyuki Suzuki, Masaru Terai, Shigeto Fuse et al. · The Lancet · 2019 · 208 citations

Medicine, Cardiology, Immunology +11

Common variants in CASP3 confer susceptibility to Kawasaki disease

Yoshihiro Onouchi, Kouichi Ozaki, Jane C. Buns et al. · Human Molecular Genetics · 2010 · 176 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Prognostic Impact of Vascular Leakage in Acute Kawasaki Disease

Masaru Terai, Takafumi Honda, Kumi Yasukawa et al. · Circulation · 2003 · 135 citations · Full text

Medicine, Internal Medicine, Pathology +9

ITPKC and CASP3 polymorphisms and risks for IVIG unresponsiveness and coronary artery lesion formation in Kawasaki disease

Yoshihiro Onouchi, Yoichi Suzuki, Hiroyuki Suzuki et al. · The Pharmacogenomics Journal · 2011 · 125 citations

Medicine, Cardiology, Genetics +16